Steven W. Lefkowitz - Feb 22, 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Steven W Lefkowitz
Stock symbol
CRMD
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:18 PM
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 60.5K Feb 22, 2022 Direct
holding CRMD Common Stock 30.2K Feb 22, 2022 Wade Capital Corp Money Purchase Plan F1
holding CRMD Common Stock 2K Feb 22, 2022 Reporting Person's Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20K $0.00 20K Feb 22, 2022 Common Stock 20K $4.03 Direct F7
holding CRMD Stock Option (Right to Buy Common Stock) 30K Feb 22, 2022 Common Stock 30K $8.32 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $5.63 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $8.30 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 8K Feb 22, 2022 Common Stock 8K $2.85 Direct F5
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $2.25 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
F2 These options were granted on 1/11/2021. These options are fully vested.
F3 These options were granted on 02/25/2020. These options are fully vested.
F4 These options were granted on 01/10/2019. The options are fully vested.
F5 These options were granted on 2/16/2018. These options are fully vested.
F6 These options were granted on 6/25/2017. These options are fully vested.
F7 These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.